Search filters

List of works by Dragana Bugarski-Kirola

Association of prominent positive and prominent negative symptoms and functional health, well-being, healthcare-related quality of life and family burden: a CATIE analysis

scientific article

Bitopertin in Negative Symptoms of Schizophrenia-Results From the Phase III FlashLyte and DayLyte Studies

scientific article

Defining therapeutic benefit for people with schizophrenia: focus on negative symptoms.

scientific article published on 09 January 2015

Effects of D-cycloserine on negative symptoms in schizophrenia

scientific article published in December 2004

Efficacy and safety of adjunctive bitopertin (10 and 20mg) versus placebo in subjects with persistent predominant negative symptoms of schizophrenia treated with antipsychotics — Results from the Phase III FlashLyte Study

Efficacy and safety of adjunctive bitopertin (5 and 10mg) versus placebo in subjects with persistent predominant negative symptoms of schizophrenia treated with antipsychotics — Results from the phase III DayLyte study

Efficacy and safety of adjunctive bitopertin versus placebo in patients with suboptimally controlled symptoms of schizophrenia treated with antipsychotics: results from three phase 3, randomised, double-blind, parallel-group, placebo-controlled, mul

scientific article published on 2 November 2016

Negative symptoms have greater impact on functioning than positive symptoms in schizophrenia: analysis of CATIE data

scientific article

Prepulse inhibition of acoustic startle in subjects with schizophrenia treated with olanzapine or haloperidol

scientific article published in August 2003

Psychometric evaluation of the Work Readiness Questionnaire in schizophrenia

scientific article published on October 2014

Reliability, validity and ability to detect change of the PANSS negative symptom factor score in outpatients with schizophrenia on select antipsychotics and with prominent negative or disorganized thought symptoms

scientific article

Report on ISCTM Consensus Meeting on Clinical Assessment of Response to Treatment of Cognitive Impairment in Schizophrenia

scientific article